Saudi Arabia In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction

GlobalData’s new report, “Saudi Arabia In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Saudi Arabia In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Saudi Arabia In Vitro Diagnosticsmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Inc., bioMerieux S.A., Becton, Dickinson and Company and others.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Saudi Arabia In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Beckman Coulter, Inc.
bioMerieux S.A.
Becton, Dickinson and Company
Ortho-Clinical Diagnostics Inc.
Bio-Rad Laboratories, Inc.
Mindray Medical International Limited
DiaSorin S.p.A
Thermo Fisher Scientific Inc.
HORIBA, Ltd.
Qiagen N.V.
Grifols, S.A.
Life Technologies Corporation
PerkinElmer, Inc.
Phadia AB
Sysmex Corporation
Gen-Probe Incorporated
DIAGNOSTICA STAGO, Inc.
Hologic, Inc.
Immucor, Inc.
Chembio Diagnostic, Inc.
[Studien Infos ausblenden]

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 14
2.1 What is This Report About? 14
3 In Vitro Diagnostics In Saudi Arabia 15
3.1 In Vitro Diagnostics, Market Segmentation 15
3.2 In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Actual, 2003-2017 16
3.3 In Vitro Diagnostics Market, Saudi Arabia, Revenue Mix ($m), 2010 18
3.4 In Vitro Diagnostics Market, Saudi Arabia, Category Contribution (%), 2010 19
3.5 In Vitro Diagnostics, Saudi Arabia, Company share (2009-2010) 26
4 Clinical Chemistry In Saudi Arabia 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2010 29
4.3 Clinical Chemistry Market, Saudi Arabia, Segment Contribution (%), 2010 30
4.4 Clinical Chemistry Overall Revenue (2003-2017) 31
4.4.1 Clinical Chemisty Analyzers Revenue (2003-2017) 35
4.4.2 Urine Analysis Revenue (2003-2017) 39
4.5 Clinical Chemistry Distribution Share (2009-2010) 43
4.6 Clinical Chemistry, Saudi Arabia, Company share (2009-2010) 44
5 Genetic Testing In Saudi Arabia 46
5.1 Genetic Testing, Market Segmentation 46
5.2 Genetic Testing Market, Saudi Arabia, Revenue Mix ($m), 2010 47
5.3 Genetic Testing Market, Saudi Arabia, Segment Contribution (%), 2010 48
5.4 Genetic Testing Overall Revenue (2003-2017) 49
5.5 Genetic Testing Distribution Share (2009-2010) 53
5.6 Genetic Testing, Saudi Arabia, Company share (2009-2010) 54
6 Haematology In Saudi Arabia 56
6.1 Haematology, Market Segmentation 56
6.2 Haematology Market, Saudi Arabia, Revenue Mix ($m), 2010 57
6.3 Haematology Market, Saudi Arabia, Segment Contribution (%), 2010 58
6.4 Haematology Overall Revenue (2003-2017) 59
6.4.1 Haematology Reagents Revenue (2003-2017) 63
6.4.2 Immunohaematology Revenue (2003-2017) 67
6.4.3 Haemostasis Revenue (2003-2017) 71
6.4.4 Haematology Rapid Tests Revenue (2003-2017) 75
6.4.5 Haematology Cell Counters Revenue (2003-2017) 79
6.5 Haematology Distribution Share (2009-2010) 83
6.6 Haematology, Saudi Arabia, Company share (2009-2010) 84
7 Histology And Cytology In Saudi Arabia 86
7.1 Histology And Cytology, Market Segmentation 86
7.2 Histology And Cytology Market, Saudi Arabia, Revenue Mix ($m), 2010 87
7.3 Histology And Cytology Market, Saudi Arabia, Segment Contribution (%), 2010 88
7.4 Histology And Cytology Overall Revenue (2003-2017) 89
7.5 Histology And Cytology Distribution Share (2009-2010) 93
7.6 Histology And Cytology, Saudi Arabia, Company share (2009-2010) 94
8 Immuno Chemistry In Saudi Arabia 96
8.1 Immuno Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2010 96
8.2 Immuno Chemistry Market, Saudi Arabia, Segment Contribution (%), 2010 97
8.3 Immuno Chemistry Overall Revenue (2003-2017) 98
8.3.1 Disease Specific Immunochemistry Revenue (2003-2017) 102
8.3.2 Drugs of Abuse / Toxicology Revenue (2003-2017) 106
8.3.3 Endocrinology Tests Revenue (2003-2017) 110
8.3.4 Therapeutic Drug Monitoring Revenue (2003-2017) 114
8.3.5 Immunochemistry Analyzers Revenue (2003-2017) 118
8.4 Immuno Chemistry Distribution Share (2009-2010) 122
8.5 Immuno Chemistry, Saudi Arabia, Company share (2009-2010) 123
9 Infectious Immunology In Saudi Arabia 125
9.1 Infectious Immunology, Market Segmentation 125
9.2 Infectious Immunology Market, Saudi Arabia, Revenue Mix ($m), 2010 126
9.3 Infectious Immunology Market, Saudi Arabia, Segment Contribution (%), 2010 127
9.4 Infectious Immunology Overall Revenue (2003-2017) 128
9.5 Infectious Immunology Distribution Share (2009-2010) 132
9.6 Infectious Immunology, Saudi Arabia, Company share (2009-2010) 133
10 Microbiology Culture In Saudi Arabia 135
10.1 Microbiology Culture, Market Segmentation 135
10.2 Microbiology Culture Market, Saudi Arabia, Revenue Mix ($m), 2010 136
10.3 Microbiology Culture Market, Saudi Arabia, Segment Contribution (%), 2010 137
10.4 Microbiology Culture Overall Revenue (2003-2017) 138
10.4.1 Microbiology Analyzers Revenue (2003-2017) 142
10.5 Microbiology Culture Distribution Share (2009-2010) 146
10.6 Microbiology Culture, Saudi Arabia, Company share (2009-2010) 147
11 Overview of Key Companies in Saudi Arabia In Vitro Diagnostics Market 149
11.1 F. Hoffmann-La Roche Ltd. 149
11.1.1 Company Overview 149
11.1.2 Share in the Saudi Arabia In Vitro Diagnostics Market 149
11.2 Siemens Healthcare 150
11.2.1 Company Overview 150
11.2.2 Share in the Saudi Arabia In Vitro Diagnostics Market 150
11.3 Abbott Laboratories 151
11.3.1 Company Overview 151
11.3.2 Share in the Saudi Arabia In Vitro Diagnostics Market 151
11.4 Beckman Coulter, Inc. 152
11.4.1 Company Overview 152
11.4.2 Share in the Saudi Arabia In Vitro Diagnostics Market 152
11.5 bioMerieux S.A. 153
11.5.1 Company Overview 153
11.5.2 Share in the Saudi Arabia In Vitro Diagnostics Market 153
11.6 Becton, Dickinson and Company 154
11.6.1 Company Overview 154
11.6.2 Share in the Saudi Arabia In Vitro Diagnostics Market 154
11.7 Ortho-Clinical Diagnostics Inc. 155
11.7.1 Company Overview 155
11.8 Bio-Rad Laboratories, Inc. 155
11.8.1 Company Overview 155
11.9 Mindray Medical International Limited 155
11.9.1 Company Overview 155
11.10 DiaSorin S.p.A 156
11.10.1 Company Overview 156
11.11 Thermo Fisher Scientific Inc. 156
11.11.1 Company Overview 156
11.12 HORIBA, Ltd. 157
11.12.1 Company Overview 157
11.13 Qiagen N.V. 157
11.13.1 Company Overview 157
11.14 Grifols, S.A. 157
11.14.1 Company Overview 157
11.15 Life Technologies Corporation 158
11.15.1 Company Overview 158
11.16 PerkinElmer, Inc. 158
11.16.1 Company Overview 158
11.17 Phadia AB 158
11.17.1 Company Overview 158
11.18 Sysmex Corporation 159
11.18.1 Company Overview 159
11.19 Gen-Probe Incorporated 159
11.19.1 Company Overview 159
11.20 DIAGNOSTICA STAGO, Inc. 159
11.20.1 Company Overview 159
11.21 Hologic, Inc. 160
11.21.1 Company Overview 160
11.22 Immucor, Inc. 160
11.22.1 Company Overview 160
11.23 Chembio Diagnostic, Inc. 160
11.23.1 Company Overview 160
12 In Vitro Diagnostics Market Pipeline Products 161
12.1 Clinical Chemisty Market Pipeline Products 161
12.2 Immuno Chemistry Market Pipeline Products 164
12.3 Haematology Market Pipeline Products 167
12.4 Infectious Immunology Market Pipeline Products 169
12.5 Microbiology Culture Market Pipeline Products 173
12.6 Histology And Cytology Market Pipeline Products 174
12.7 Genetic Testing Market Pipeline Products 175
13 Appendix 179
13.1 Definitions of Markets Covered in the Report 180
13.1.1 In Vitro Diagnostics 180
13.2 Research Methodology 190
13.3 Secondary Research 190
13.4 Primary Research 191
13.5 Models 191
13.6 Forecasts 192
13.7 Expert Panels 192
13.8 GlobalData Consulting 192
13.9 Currency Conversion 193
13.10 Contact Us 193
13.11 Disclaimer 193
[Inhaltsverzeichnis ausblenden]

1.1 List of Tables
Table 1: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Actual, 2003-2017 17
Table 2: In Vitro Diagnostics Market, Saudi Arabia, Category Contribution (%), 2010 19
Table 3: In Vitro Diagnostics, Saudi Arabia, Cross-Category Analysis, 2003-2017 21
Table 4: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Actual, Historic, 2003-2010 23
Table 5: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 25
Table 6: In Vitro Diagnostics, Saudi Arabia, Company share by Revenue ($m), USD Actual, 2009-2010 27
Table 7: Clinical Chemistry Market, Saudi Arabia, Segment Contribution (%), 2010 30
Table 8: Clinical Chemistry, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 32
Table 9: Clinical Chemistry, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 34
Table 10: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 36
Table 11: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 38
Table 12: Urine Analysis, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 40
Table 13: Urine Analysis, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 42
Table 14: Clinical Chemistry, Saudi Arabia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 43
Table 15: Clinical Chemistry, Saudi Arabia, Company share by Revenue ($m), USD Actual 2009-2010 45
Table 16: Genetic Testing Market, Saudi Arabia, Segment Contribution (%), 2010 48
Table 17: Genetic Testing, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 50
Table 18: Genetic Testing, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 52
Table 19: Genetic Testing, Saudi Arabia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 53
Table 20: Genetic Testing, Saudi Arabia, Company share by Revenue ($m), USD Actual 2009-2010 55
Table 21: Haematology Market, Saudi Arabia, Segment Contribution (%), 2010 58
Table 22: Haematology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 60
Table 23: Haematology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 62
Table 24: Haematology Reagents, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 64
Table 25: Haematology Reagents, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 66
Table 26: Immunohaematology, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 68
Table 27: Immunohaematology, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 70
Table 28: Haemostasis, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 72
Table 29: Haemostasis, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 74
Table 30: Haematology Rapid Tests, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 76
Table 31: Haematology Rapid Tests, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 78
Table 32: Haematology Cell Counters, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 80
Table 33: Haematology Cell Counters, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 82
Table 34: Haematology, Saudi Arabia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 83
Table 35: Haematology, Saudi Arabia, Company share by Revenue ($m), USD Actual 2009-2010 85
Table 36: Histology And Cytology Market, Saudi Arabia, Segment Contribution (%), 2010 88
Table 37: Histology And Cytology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 90
Table 38: Histology And Cytology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 92
Table 39: Histology And Cytology, Saudi Arabia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 93
Table 40: Histology And Cytology, Saudi Arabia, Company share by Revenue ($m), USD Actual 2009-2010 95
Table 41: Immuno Chemistry Market, Saudi Arabia, Segment Contribution (%), 2010 97
Table 42: Immuno Chemistry, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 99
Table 43: Immuno Chemistry, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 101
Table 44: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 103
Table 45: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 105
Table 46: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 107
Table 47: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 109
Table 48: Endocrinology Tests, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 111
Table 49: Endocrinology Tests, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 113
Table 50: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 115
Table 51: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 117
Table 52: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 119
Table 53: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 121
Table 54: Immuno Chemistry, Saudi Arabia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 122
Table 55: Immuno Chemistry, Saudi Arabia, Company share by Revenue ($m), USD Actual 2009-2010 124
Table 56: Infectious Immunology Market, Saudi Arabia, Segment Contribution (%), 2010 127
Table 57: Infectious Immunology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 129
Table 58: Infectious Immunology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 131
Table 59: Infectious Immunology, Saudi Arabia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 132
Table 60: Infectious Immunology, Saudi Arabia, Company share by Revenue ($m), USD Actual 2009-2010 134
Table 61: Microbiology Culture Market, Saudi Arabia, Segment Contribution (%), 2010 137
Table 62: Microbiology Culture, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 139
Table 63: Microbiology Culture, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 141
Table 64: Microbiology Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 143
Table 65: Microbiology Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 145
Table 66: Microbiology Culture, Saudi Arabia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 146
Table 67: Microbiology Culture, Saudi Arabia, Company share by Revenue ($m), USD Actual 2009-2010 148
Table 68: Clinical Chemisty Market Pipeline Products 161
Table 69: Immuno Chemistry Market Pipeline Products 164
Table 70: Haematology Market Pipeline Products 167
Table 71: Infectious Immunology Market Pipeline Products 169
Table 72: Microbiology Culture Market Pipeline Products 173
Table 73: Histology And Cytology Market Pipeline Products 174
Table 74: Genetic Testing Market Pipeline Products 175
Table 75: USD to Local Currency, Saudi Arabia, Average Actual Rate 2003-2010 193
1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 15
Figure 2: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Actual, 2003-2017 16
Figure 3: In Vitro Diagnostics Market, Saudi Arabia, Revenue Mix ($m), 2010 18
Figure 4: In Vitro Diagnostics Market, Saudi Arabia, Category Contribution (%), 2010 19
Figure 5: In Vitro Diagnostics, Saudi Arabia, Cross-Category Analysis, 2003-2017 20
Figure 6: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22
Figure 7: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 24
Figure 8: In Vitro Diagnostics, Saudi Arabia, Company share (%), 2010 26
Figure 9: Clinical Chemistry, Market Segmentation 28
Figure 10: Clinical Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2010 29
Figure 11: Clinical Chemistry Market, Saudi Arabia, Segment Contribution (%), 2010 30
Figure 12: Clinical Chemistry, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 31
Figure 13: Clinical Chemistry, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 33
Figure 14: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 35
Figure 15: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 37
Figure 16: Urine Analysis, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 39
Figure 17: Urine Analysis, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 41
Figure 18: Clinical Chemistry, Saudi Arabia, Company share (%), 2010 44
Figure 19: Genetic Testing, Market Segmentation 46
Figure 20: Genetic Testing Market, Saudi Arabia, Revenue Mix ($m), 2010 47
Figure 21: Genetic Testing Market, Saudi Arabia, Segment Contribution (%), 2010 48
Figure 22: Genetic Testing, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 49
Figure 23: Genetic Testing, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 51
Figure 24: Genetic Testing, Saudi Arabia, Company share (%), 2010 54
Figure 25: Haematology, Market Segmentation 56
Figure 26: Haematology Market, Saudi Arabia, Revenue Mix ($m), 2010 57
Figure 27: Haematology Market, Saudi Arabia, Segment Contribution (%), 2010 58
Figure 28: Haematology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 59
Figure 29: Haematology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 61
Figure 30: Haematology Reagents, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 63
Figure 31: Haematology Reagents, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 65
Figure 32: Immunohaematology, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 67
Figure 33: Immunohaematology, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 69
Figure 34: Haemostasis, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 71
Figure 35: Haemostasis, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 73
Figure 36: Haematology Rapid Tests, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 75
Figure 37: Haematology Rapid Tests, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 77
Figure 38: Haematology Cell Counters, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 79
Figure 39: Haematology Cell Counters, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 81
Figure 40: Haematology, Saudi Arabia, Company share (%), 2010 84
Figure 41: Histology And Cytology, Market Segmentation 86
Figure 42: Histology And Cytology Market, Saudi Arabia, Revenue Mix ($m), 2010 87
Figure 43: Histology And Cytology Market, Saudi Arabia, Segment Contribution (%), 2010 88
Figure 44: Histology And Cytology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 89
Figure 45: Histology And Cytology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 91
Figure 46: Histology And Cytology, Saudi Arabia, Company share (%), 2010 94
Figure 47: Immuno Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2010 96
Figure 48: Immuno Chemistry Market, Saudi Arabia, Segment Contribution (%), 2010 97
Figure 49: Immuno Chemistry, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 98
Figure 50: Immuno Chemistry, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 100
Figure 51: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 102
Figure 52: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 104
Figure 53: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 106
Figure 54: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 108
Figure 55: Endocrinology Tests, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 110
Figure 56: Endocrinology Tests, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 112
Figure 57: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 114
Figure 58: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 116
Figure 59: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 118
Figure 60: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 120
Figure 61: Immuno Chemistry, Saudi Arabia, Company share (%), 2010 123
Figure 62: Infectious Immunology, Market Segmentation 125
Figure 63: Infectious Immunology Market, Saudi Arabia, Revenue Mix ($m), 2010 126
Figure 64: Infectious Immunology Market, Saudi Arabia, Segment Contribution (%), 2010 127
Figure 65: Infectious Immunology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 128
Figure 66: Infectious Immunology, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 130
Figure 67: Infectious Immunology, Saudi Arabia, Company share (%), 2010 133
Figure 68: Microbiology Culture, Market Segmentation 135
Figure 69: Microbiology Culture Market, Saudi Arabia, Revenue Mix ($m), 2010 136
Figure 70: Microbiology Culture Market, Saudi Arabia, Segment Contribution (%), 2010 137
Figure 71: Microbiology Culture, Saudi Arabia, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 138
Figure 72: Microbiology Culture, Saudi Arabia, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 140
Figure 73: Microbiology Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 142
Figure 74: Microbiology Analyzers, Saudi Arabia, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 144
Figure 75: Microbiology Culture, Saudi Arabia, Company share (%), 2010 147
Figure 76: F. Hoffmann-La Roche Ltd., Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2010 149
Figure 77: Siemens Healthcare, Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2010 150
Figure 78: Abbott Laboratories, Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2010 151
Figure 79: Beckman Coulter, Inc., Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2010 152
Figure 80: bioMerieux S.A., Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2010 153
Figure 81: Becton, Dickinson and Company, Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2010 154
[Tabellenverzeichnis ausblenden]